Neurocrine Biosciences
NBIX
#1384
Rank
NZ$26.60 B
Marketcap
NZ$266.86
Share price
0.83%
Change (1 day)
15.74%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company